
The rise of GLP-1 drugs is exposing long-standing flaws in fashion’s approach to sizing, inventory planning and fit, creating both disruption and opportunity for brands.
Over the last three years, Holly Ann Burningham, vice president of design for intimates maker Soma, has lost 90 pounds with the help of GLP-1 medication. But the process turned out to be more than a personal milestone — it doubled as research for the brand.
Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.
Join thousands of readers who get XOTLIST delivered daily. No spam, ever. Unsubscribe anytime.